Search results

Articles (6)

Journals (0)

1-6 of 6 results for ORACLE-MS

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published January, 2021

Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study

Mark S Freedman, Patricia K Coyle, Giancarlo Comi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open accessResearch articleFirst published December, 2017

The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study

Mark S Freedman, Thomas P Leist, Giancarlo Comi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Restricted accessResearch articleFirst published January, 2025

Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort

Gavin Giovannoni, Alexey Boyko, Jorge Correale [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published 2019

Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

Olaf Stuve, Per Soelberg Soerensen, Thomas Leist [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published July, 2021

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

Jiwon Oh, Bryan Walker, Gavin Giovannoni [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open accessResearch articleFirst published 2020

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

Francesco Patti, Andrea Visconti, Antonio Capacchione [...]

Therapeutic Advances in Neurological Disorders

Search results

Articles (6)

Journals (0)

1-6 of 6 results for ORACLE-MS

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published January, 2021

Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study

Mark S Freedman, Patricia K Coyle, Giancarlo Comi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open accessResearch articleFirst published December, 2017

The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study

Mark S Freedman, Thomas P Leist, Giancarlo Comi [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Restricted accessResearch articleFirst published January, 2025

Long-term follow-up of patients with a first clinical demyelinating event (clinically isolated syndrome) who received cladribine tablets in CLASSIC-MS: Findings for the ORACLE-MS cohort

Gavin Giovannoni, Alexey Boyko, Jorge Correale [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published 2019

Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers

Olaf Stuve, Per Soelberg Soerensen, Thomas Leist [...]

Therapeutic Advances in Neurological Disorders

Open accessResearch articleFirst published July, 2021

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

Jiwon Oh, Bryan Walker, Gavin Giovannoni [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Open accessResearch articleFirst published 2020

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

Francesco Patti, Andrea Visconti, Antonio Capacchione [...]

Therapeutic Advances in Neurological Disorders